This inventor holds 1 USPTO granted patent. Top assignee: Mitsui Toatsu Chemicals, Incorporated. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: **Innovator Spotlight: Ayako Watanabe - A Pioneer in Monoclonal Antibody Development**
Introduction
Ayako Watanabe is a distinguished inventor based in Chiba-ken, Japan, recognized for her significant contributions in the field of biotechnology. With a focus on developing advanced therapeutic solutions, Watanabe's work has garnered attention for its potential impact on human health.
Latest Patents
Watanabe holds a patent for an innovative anti-VEGF human monoclonal antibody. This invention presents a groundbreaking method to neutralize the vascular endothelial growth factor (VEGF) activity, which plays a crucial role in vascularization. The patent details a process involving the creation of a human monoclonal antibody, capable of binding specifically to VEGF, inhibiting the migration and proliferation of vascular endothelial cells. Additionally, the invention includes hybridoma strains VA01 and BL2 that produce this antibody, formed through the transformation of human lymphocytes with Epstein-Barr Virus (EBV) followed by fusion with human myeloma cells.
Career Highlights
Ayako Watanabe is associated with Mitsui Toatsu Chemicals, Incorporated, a leading player in the chemical industry. Her role at the company has allowed her to explore and develop innovative solutions that bridge chemistry and healthcare. The patent she holds exemplifies her dedication to advancing medical research and improving therapeutic strategies.
Collaborations
Throughout her career, Watanabe has collaborated with fellow scientists such as Hisayoshi Ooka and Shiro Takagi. These partnerships have enabled her to enhance her research, share insights, and work towards common goals in the field of monoclonal antibody development.
Conclusion
Ayako Watanabe's contributions to the field of biotechnology through her patented inventions highlight her as a leading figure in innovation. Her work on anti-VEGF human monoclonal antibodies underscores the importance of research and development in creating solutions that may significantly improve human health outcomes. As her career progresses, Watanabe continues to inspire future inventors and researchers in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile